Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
GT Biopharma, Inc. (GTBP)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| May. 11, 2026 | CORRESP | Neutral/Informational | Moderate | GT Biopharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-1. They are seeking to have the registra… | Read Filing EDGAR |
| May. 6, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to GT Biopharma, Inc. that it will not review their registration statement filed on April 30, 2026. The letter emphasizes the company's responsibility for… | Read Filing EDGAR |
| Jan. 28, 2026 | CORRESP | Neutral/Informational | Moderate | GT Biopharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-1. They are seeking to have the registra… | Read Filing EDGAR |
| Jan. 27, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to GT Biopharma, Inc. that it will not review their registration statement filed on January 21, 2026. The letter emphasizes that the responsibility for th… | Read Filing EDGAR |
| Dec. 2, 2025 | CORRESP | Neutral/Informational | Moderate | GT Biopharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-1. They are seeking to have the registra… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.